Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Newly-identified compounds have succeeded in blocking a critical hep B enzyme; they may lead to new drug class and even cure for the virus.
Promising results in studies are tempered by myriad barriers against successfully treating and curing the disease in real world settings.
Investigational agents daclatasvir and asunaprevir have shown high cure rates among prior null-responders with difficult-to-treat strains of h...
Danoprevir and mericitabine, two experimental hepatitis C therapies, proved safe and effective among patients with previous treatment experien...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.